Objectives: To locate the acquired bla OXA-23 carbapenem resistance gene in an Australian A. baumannii global clone 1 (GC1) isolate.
Introduction
Carbapenems are an important class of antibiotic used to treat Acinetobacter baumannii infections. However, many isolates are carbapenem resistant, most often due to the acquisition of an oxacillinase that is able to inactivate imipenem and meropenem. Several genes that confer resistance to carbapenems have been reported in this species. 1 The bla OXA-23 gene has been seen in several different contexts. 2 In the composite transposon Tn2006, the bla OXA-23 gene is flanked by inversely oriented copies of ISAba1, 3 and Tn2006 has been detected in several different genetic contexts in the chromosome or in a plasmid. 2 One location is within the AbGRI1-type island, Tn6167, found in Australian global clone 2 (GC2) strains. 4 Tn2006 is also in AbaR4, 5 a compound transposon made up of a Tn6022 backbone with Tn2006 in the end of the sup gene. 6 Hence, the bla OXA-23 gene can be disseminated by both of these transposon types. Since AbaR4 was first identified in the chromosome of a global clone 1 (GC1) isolate, 5 it has also been found in the comM gene of a distinct GC1 lineage. 6 Transfer of bla OXA-23 into further strains by repAci6 conjugative plasmids has been reported, 7 but little is known about these plasmids.
The bla OXA-23 gene is present in most Australian carbapenemresistant A. baumannii isolates but carbapenem resistance is rare in the GC1 isolates. 6,8 -10 The GC1 isolate A85 is resistant to carbapenems (imipenem and meropenem), and to ceftazidime and cefotaxime as well as sulphonamides, tetracycline and gentamicin. 6, 11 Resistance to third-generation cephalosporins was recently traced 11 Here, the whole genome sequence of A85 was determined and used to confirm the composition of the genomic antibiotic resistance islands and plasmids present, and to determine the location of Tn2006.
Materials and methods

DNA sequencing and sequence analysis
Genomic DNA isolated from A85 was sequenced using Illumina HiSeq at the Wellcome Trust Sanger Institute. Paired-end reads of 100 bp were assembled using Velvet, 12 yielding 124 contigs with an average read depth of 60-fold. Contigs carrying parts of the AbaR0/AbaR3-type and AbaR4 islands were recovered using standalone BLAST searches (www. ncbi.nlm.nih.gov/books/NBK52640) and assembled using sequences of fragments amplified using PCR with published primers. 6, 13 Parts of plasmids were identified as described previously, 14 and junctions between contigs predicted by comparison with related plasmids were confirmed using published primers, 14 and further primers listed in Table S1 (available as Supplementary data at JAC Online), and the amplicons were sequenced. Sequencher 5.2.3 (Gene Codes Corporation, Ann Arbor, MI, USA) was used for final sequence assembly. Gene clusters for the synthesis of the capsule and the outer core of lipooligosaccharide were found as described previously. 15 Reading frames were predicted using ORF Finder (www.ncbi.nlm.nih.gov/projects/gorf/) and annotated manually. In addition, sequence type (ST) in the Oxford (http://pubmlst.org/abaumannii/) and Institut Pasteur (http://www.pasteur.fr/recherche/genopole/PF8/ mlst/Abaumannii.html) schemes were determined from the genome sequence as described previously.
11
Conjugation
Matings were performed as described previously, 14 and transconjugants recovered on L-agar plates containing rifampicin (100 mg/L) to select for the recipient, a spontaneous rifampicin-resistant mutant of A. baumannii ATCC 17978 (resistant to sulphonamides), and ticarcillin (100 mg/L) to select for plasmid transfer. Spontaneous rifampicin-resistant derivatives of the donor were eliminated by screening purified potential transconjugants on L-agar containing ceftazidime (20 mg/L), to which the donor is resistant and the recipient susceptible. Ceftazidime-susceptible transconjugants were tested for resistance to antibiotics using disc diffusion.
GenBank accession numbers
The sequences of pA85-1, pA85-2 and pA85-3 were deposited in GenBank under accession numbers, KJ461963, KJ477078 and KJ493819, respectively. The Tn6168, AbaR3, gyrA and parC, OCL3 and KL15 sequences are in GenBank under accession number KC118540.
Results and discussion
A85, a GC1 isolate exhibiting extensive resistance to antibiotics
In addition to the resistance phenotypes reported previously, A85 was found to be resistant to ticarcillin/clavulanate (due to bla OXA-23 ), sulbactam and fluoroquinolones, nalidixic acid and ciprofloxacin (Table 1) . A85 was susceptible to colistin (MIC of 0.125 mg/L). Hence, using current definitions, 16 A85 is extensively resistant. The genome sequence predicts a serine residue at 83 in GyrA and at 80 in ParC, explaining the fluoroquinolone resistance.
A85 was previously shown by PCR mapping to carry the AbaR3 resistance island in comM.
11 AbaR3 5 includes aacC1, conferring resistance to gentamicin, and aadA1 (streptomycin and spectinomycin) in cassettes in the aacC1-orfP-orfQ-aadA1 cassette configuration in a class 1 integron with a sul1 (sulphonamide resistance) gene, and the aphA1b gene (kanamycin and neomycin) in Tn6020, the tet(A) tetracycline resistance determinant and the bla TEM gene. These genes were found in the A85 genome and the complete 62 989 bp island was assembled from 15 contigs using PCR primers published previously to link them.
Conjugative plasmid pA85-3 carries AbaR4
The bla OXA-23 carbapenem resistance gene of A85 is in Tn2006 but this transposon was not found in the AbaR3 island or flanked by chromosomal genes. Instead, Tn2006 was in AbaR4. A85 contains three plasmids. The largest, pA85-3 (Figure 1 ), includes the AbaR4 surrounded by a 5 bp duplication (CCATT) that occurs only once in pAb-G7-2 (GenBank accession number KF669606). pA85-3 resembles pAb-G7-2 in that it comprises three segments separated by a repeated segment (grey boxes in Figure 1 ; 2 and 3 are 423 bp and 1 is 225 bp).
pA85-3 carries the rep gene designated repAci6 7 and two separate regions with genes involved in conjugal transfer. The tra genes in Figure 1 are responsible for mating pair formation (MPF or type IV secretion system) and the second region contains the mobilization genes trwC and trwB. pA85-3 was shown to transfer ticarcillin/clavulanate, imipenem and meropenem resistance into a carbapenem-susceptible A. baumannii recipient strain, ATCC 17978 rif R (Table 1) . Recently, a sequenced repAci6 plasmid, Hamidian et al.
pAb-G7-2, was shown to transfer TnaphA6, 14 and this group appears to be responsible for the most recent resistance gene acquisition in A. baumannii.
Detection of AbaR4 in the pA85-3 context
The locations of transposons represent simple, useful markers for specific plasmids. Primers that amplify the left or right-hand boundaries of AbaR4 with the plasmid backbone found in pA85-3 (primer locations shown in Figure 1 and sequences listed in Table S1 ) were used to examine the additional carbapenemresistant isolates in our collection that were found to carry AbaR4. Only two isolates, both GC1, met this criterion and the AbaR4 transposon was found to be in exactly the same location in one 2011 isolate, D108. In the second, AbaR4 was in comM. As this suggested that D108 carries a plasmid identical or closely related to pA85-3, the genome sequence of this isolate was determined and an essentially identical plasmid (five single-nucleotide polymorphisms) was assembled from it.
It would be interesting to know whether the conjugative repAci6 plasmids reported previously 7 are identical to pA85-3 or whether they carry the bla OXA-23 gene in a different context. The eight European A. baumannii isolates that carried a repAci6 plasmid and bla OXA-23 17 may also contain pA85-3. This can now be tested using the PCR primers developed here.
The plasmid p2ABTCDC0715 (70 894 bp; GenBank accession number CP002524) from a GC2 isolate is closely related to pA85-3 but is cryptic. However, though the available sequence does not include AbaR4, part of each inverted repeat is present, flanked by the same 5 bp duplication as in pA85-3, and it is possible that AbaR4 has been omitted from the assembly. A similar omission was recently found for pACICU-2. 18 Searches of the available A. baumannii draft genomes in GenBank (last searched March 2014) revealed contigs that contained a fragment of AbaR4 adjacent to the flanking sequence in pA85-3, indicating that they may also contain pA85-3 or a close relative. One of these isolates, Ab210, belonged to GC2, and was previously reported to have a deletion derivative of AbaR4 in the comM gene (GenBank accession number HQ700358). 19 This conclusion now needs to be reassessed. One further draft genome for AC30 (a GC2 isolate from Malaysia) includes contigs for all of the components of pA85-3.
Other distinguishing features
A85 also includes two small cryptic plasmids. pA85-1 is 2726 bp and differs from p4ABAYE (GenBank accession number CU459139) at 66 positions. pA85-2 is an 8731 bp plasmid that differs from pAb-G7-1 (GenBank accession number KJ586856) 14 by a single base substitution and from pAB0057 (GenBank accession number CP001183) by two additional bases. 5 From the genome sequence, A85 was ST1 (Institut Pasteur scheme), consistent with the GC1 assignment. Under the Oxford scheme A85 was known to be ST126 (10-53-4-11-4-64-5), differing by two alleles from ST109 (10-12-4-11-4-9-5) found in many Australian GC1 isolates, 11 and in the 1984 GC1 reference isolate, A297 (RUH875). 20 However the gpi allele is 200 rather than 64 when the genome sequence is used. As one of the differences between ST126 and ST109 is in the gpi allele, which was recently shown to be located in the gene cluster directing capsule biosynthesis, 15 and two different gene clusters directing capsule biosynthesis have been reported at this locus in GC1 isolates, 5, 15 this region of the G7 genome was examined. A novel K locus, KL15, was identified ( Figure S1 , available as Supplementary data at JAC Online), indicating that this segment of the genome had been replaced again. KL15 has two sugar synthesis modules, dgaABC for 2,3-diacetamido-2,3-dideoxy-a-D-glucuroninic acid that is similar to a module in KL3, 15 and qhbCB-gdr for a bacillosamine relative. The outer core locus was identified as OCL3. 15 
Conclusions
The conjugative ability of the carbapenem resistance plasmid pA85-3 has allowed it to become widespread, disseminating the bla OXA-23 gene into the GC1 and GC2 clones. The PCRs developed will allow it to be tracked globally. Table S1 . 
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